CapitalStars Financial Research Pvt Ltd

CapitalStars

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market.we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX. Read More

Commodity Market Services

Commodity Market Services

In this service we provide 3-4 intraday calls in MCX with a high level of accuracy. The calls are given in Precious Metals, Base Metals and Energies. You can also avail Free Tips for two days to test our accuracy and if satisfied you can join the services with Capital Stars. Read More

Nifty Market Services

Nifty Future Services

We provide you around 1-2 nifty calls, Bank Nifty Futures, nifty futures tips, sgx nifty tips Daily. You can gain more profit, Get 2 days free trial calls. Read More

Equity Market Services

Equity Market Services

In this service we provide 2-4 intraday stock cash calls in NSE/BSE with a high level of accuracy.You can also avail Free Stock Tips for two days to test our accuracy and if satisfied you can join stock cash services with Capital Stars. Read More

Register now

CapitalStars provides Free Trial in Intraday as well as in Positional Services of Equity, Derivatives, and Commodities and Forex Markets. We provide recommendations in NSE, BSE, MCX, NCDEX, and MCX-SX etc. We render you enough entry and exit time in our calls so clients can easily maximize their profits. Read More

Monday 23 October 2017

Capitalstars Updates: Positive opening for the Indian equities: 23 Oct 2017

Capitalstars Updates: Equity Market Outlook

Indian Indices:

SGX Nifty indicating a positive opening for the Indian equities in line with its global peers. SGX Nifty indicating a positive opening for the Indian equities in line with its global peers.Equity benchmarks started off the week on a positive note Monday, with the Nifty reclaiming 10,150 level on short covering after over a percent loss seen in a previous week. The market opened after a long weekend.

The 30-share BSE Sensex was up 80.01 points at 32,469.97 and the 50-share NSE Nifty gained 30.30 points at 10,176.80.Hero Motocorp, Bharti Airtel, Dr. Reddy's Labs, Infosys, HUL, Cipla, TCS and Reliance Industries gained 1-2 percent. Bajaj Auto, Axis Bank, HDFC, Indiabulls Real, UPL, and HPCL were under pressure in early trade. Nifty Midcap was up 0.2 percent on positive market breadth. Bhushan Steel, Uttam Galva, Monnet Ispat, Visa Steel, 63 Moons, Dwarikesh Sugar, Puravankara Projects, Radico Khaitan and Gati rallied 2-10 percent. Sintex Industries, Canara Bank, Andhra Bank and Titan Company were down 1 percent.

Global Market:

• Asia Stock Japanese PM Shinzo Abe’s coalition secured a whopping a 2/3rd majority after winning 312 seats out of 465 at Sunday's election. Nikkei 225 surged ~1% on account of these developments and extended its winning streak for the second week in a row.
• US: Wall street hits a record high as the plan of biggest tax reform optimism weighed in. The Dow Jones Industrial Average rose 165.59 points or 0.79%, to end up at 23329 levels, while tech-heavy Nasdaq edged up 0.35 points to 6,629 levels.
• Europe closed modestly higher in its last trading session with FTSE up 0.19%, CAC up 0.08%, DAX up 0.01%

Major Headlines of the day:

• M&M 
o Approves scheme of arrangement between Mahindra Two Wheelers & M&M.
o Mumbai Bench of NCLT sanctions scheme of amalgamation of Defence Land Systems India with Mahindra Defence System.

• Hindustan Unilever in focus: Parent Unilever reports results
o Commentary on India: Volume growth improved after GST implementation.
o CEO Paul Polman says starting to see signs of improvement in India and China.
o Alert: HUL Q2 Results on October 25, 2017.

• Dr. Reddy's Labs in focus
o US Court rules that patent for contraception device NuvaRing’s expiring on April 8, 2018, is valid.
o Assumption now is all generic filers including Dr Reddy's Labs can launch post-April 2018, subject to approval.
o Product worth is USD 780 million in branded sales.

Trend in FII flows: The FIIs were net buyers of Rs -43.74 the cash segment on Thursday while the DIIs were net sellers of Rs 40.78 as per the provisional figures.

UPCOMING RESULTS:- HAVELLS,IBULHSGFIN,HIND ZINC,ZUARI, 

Securities in Ban For Trade Date 23-OCT-2017:

1.BEML
2.DHFL
3.HDIL
4.IBREALEST
5.INFIBEAM
6.JPASSOCIAT
7.JSWENERGY
8.RELCAPITAL

Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It daily provides intraday and Future calls.We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities.
Also u can visit :-
capitalstars past performance

Get more details here:-

Trading Tips
Stock Tips
* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

0 comments:

Post a Comment